Sterile Medical Packaging Market Size, Share, Industry, Forecast and outlook (2024-2031)

Sterile Medical Packaging Market Overview

The Global Sterile Medical Packaging Market was valued at 39.6 Bn USD in 2022 and is expected to reach 78.7 Bn USD by 2030, exhibiting a CAGR of 9.2% during the forecast period (2024-2031). The market is expected to grow because it becomes important in different industries like Pharmaceutical & Biopharmaceutical, Surgical and Medical Appliances, IVD . The competitive rivalry intensifies with Amcor PLC, Dupont De Nemours, Inc., 3M Company, and others operating in the market.

The sterile packaging products primarily help protect drugs and medical devices, among other pharmaceutical products, from getting contaminated or physical damage. These are tear-resistant, durable, breathable, and have a superior microbial barrier, making the packaging sterile and safe. Good quality, strength, and performance in the sterile barrier can improve the reliability and efficiency of processing and handling the supplies.

Sterile Medical Packaging Market Scope
Metrics
Details
Market CAGR: 9.20%
Segments Covered: By Product Type, By Application, By Material Type, and By Region
Report Insights Covered: Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights.
Fastest Growing Region: Asia Pacific
Largest Market Share: North America

To know more insights Download Sample: https://www.datamintelligence.com/download-sample/sterile-medical-packaging-market

Sterile Medical Packaging Market Trends
The growing sterile medical packaging market is driven by the increasing awareness regarding sterilization practices, the rise in demand for single-use medical equipment, and the surge in usage of sterile packaging systems. In addition, the rise in healthcare awareness among consumers regarding sterile medical supplies, rise in adoption of advanced healthcare devices, increase in demand of disposable devices by ambulatory surgical centers, ongoing development of single disposable use sterile packaging through R & D activities are some factors that drive the growth of the sterile medical packaging market.

The high consumption rate of sterile medical packaging in the healthcare and pharmaceutical industries is expected to drive growth in the forecast period.

The sterile medical packaging market is witnessing growing demand from the healthcare industry, specifically the biotechnology industry. The use of plastics and paper & paperboard offers advantages, such as low weight, recyclability, and longevity. Sterile medical packaging also helps protect from damage caused by environmental conditions, such as moisture during transit, leading to a rise in demand from the medical sector. Properties such as microbial barriers make sterile medical packaging the perfect choice in the healthcare industry, used for packaging medical devices and pharmaceutical products. The sterile medical packaging market has a positive outlook due to increasing health awareness and growing concerns for infection control. Handling sterile medical packaging products is convenient, which drives its demand. The rising consumer income level will move consumer preference toward increased spending on healthcare services, which will support the growth of sterilized medical packaging products. These products require sterile packaging to withstand moisture and other environmental influences that may affect pharmaceutical products. For instance, In June 2020, Placon, a manufacturer of injection molded and thermoformed plastic packaging products headquartered in the United States announced it is planning to expand its thermoforming production capacity in Elkhart (Indiana).

Stringent regulatory standards for sterile medical packaging are likely to hamper market growth.

Strict regulations concerning the specifications and materials used by the firms in manufacturing sterile medical packaging are expected to restrain the market growth. Compliance with the regulations is required as the small flaw in the packaging can contaminate the product and endanger a patient's life. For instance, Food and Drug Administration (FDA) has established several sterilization validation standards, such as ISO 11137 consensus standard for radiation validation. Such standards necessitate specialized skills, resources, money and time, that limit the growth of sterile medical packaging.



COVID-19 Impact on Sterile Medical Packaging Market
The ongoing COVID-19 pandemic has posted a significant impact on market growth. Healthcare systems worldwide are being put under unprecedented strain by the devastating impact of COVID-19. Hospital sterilization centers are experiencing increased pressure to ensure the safety of both patients and frontline healthcare workers. The pandemic has opened up opportunities for innovation. Uflex, an FMCG and pharma package manufacturing firm, expects COVID-19 to propel the development of sterile and anti-microbial packaging solutions.

Sterile Medical Packaging Market Segmentation Analysis
The plastic segment is expected to hold the largest share in this market segment.

Plastic is the largest and fastest-growing raw material used in sterile medical packaging. They are mainly preferred in medical packaging, including polyvinyl chloride (PVC), polypropylene (PP), polycarbonate (PC), high impact polystyrene (HIPS), polyethylene terephthalate (PET) and high-density polyethylene. These plastics are ideal for medical packaging solutions as they offer easy moldability, cost-effectiveness, and protective properties. They protect the drugs, devices and medical instruments from contamination and damage.

A huge number of partnerships in the industry have resulted in several innovations. The collaborative efforts between the chemical/polymer resin companies and medical device packaging converters have primarily resulted in new technologies and products. For instance, In November 2019, Sonoco, one of the most sustainable, global packaging companies, acquired Thermoform Engineered Quality, LLC, and Plastique Holdings, LTD, also known as TEQ, a global manufacturer of thermoformed packaging serving healthcare and medical devices. For example, the metallocene is a linear low-density polyethylene that offers greater seal integrity and robust performance. The new oxygen and moisture-barrier resins are autoclave sterilization compatible. The new polymer chemistries offer improved thermoformability performance in both speed and quality. The key focus of the manufacturers has been the improvement of the overall performance of the sterile barrier medical device packaging. This primarily relates to elements, such as physical properties, aged package stability, sterile barrier performance, ease of opening, and materials clarity.

Moreover, hospitals have influenced the packaging industry by demanding more recyclability from the materials used for sterile packaging. Additionally, the ongoing demand for lower costs/pricing drives various innovations in the industry with materials and packaging designs. In June 2020, Placon, a manufacturer of injection molded and thermoformed plastic packaging products headquartered in the United States, announced it is planning to expand its thermoforming production capacity in Elkhart (Indiana). This is intended to meet the increasing demand for medical packaging. Likewise, other such companies gradually contribute to the sterile medical packaging industry.

The thermoform tray segment is expected to hold the largest share in this market segment.

These thermoform trays are versatile and easy to transport because of their low weight. Thermoformed trays are manufactured from plastics, come in a wide variety of shapes and sizes, and are equipped for internal use. Plastic trays have a highly versatile packaging design as the plastics used for trays can be molded to form different shapes by the thermoforming process. This versatility makes them advantageous for everything. Semi-rigid and flexible are two types of thermoform trays used in healthcare. For example, Thermoformed trays sealed with DuPont Tyvek® lipstock are 100% synthetic material made from high-density spun bound polyethylene fibers. It is lightweight, durable and breathable, yet resistant to water, abrasion, bacterial penetration and aging.

For instance, in April 2021, Amcor announced consumer trials of the world's prime recyclable Polyethylene-based thermoform blister packaging, building on its recent developments to offer recyclable packaging. The new packaging meets the strict criteria of highly specialized and regulated pharmaceutical packaging while also providing a more sustainable alternative to the most popular healthcare packaging. This innovation also benefits from a carbon footprint reduction of up to 70%.

The pharmaceutical & biopharmaceutical segment is expected to hold the largest share in this market segment.

The pharmaceutical & biopharmaceutical application is projected to lead the sterile medical packaging market. The growth of this segment can be attributed to the growing healthcare industry and the advent of new healthcare medicines. Technological advancements have optimized and integrated the sterile packaging process of pharmaceutical products and made it more capital-intensive. This process reduces the risk of contamination. More than 80 classes of over-the-counter (OTC) medications are prescribed every year, ranging from acne to weight loss products. In 2019, the United States was still the largest single pharmaceutical market, generating more than 490 billion US revenue. Europe was responsible for generating around 195 billion US dollars. The processing and packaging of pharmaceutical & biological products go through various inspections and quality checks and ensure that they adhere to regulatory compliance about the drug contents and the material used in packaging. Several pharmaceutical companies have switched to environmentally friendly sterile packaging to meet their sustainability goals. For instance, in September 2020, Johnson & Johnson consumer health division invested $800 million through 2030 to adopt future sustainable packaging solutions.

Sterile Medical Packaging Market Geographical Growth
North America region holds the largest market share of the global sterile medical packaging market.

North America is expected to be one of the largest markets for sterile medical packaging, primarily owing to the many players and stringent regulations imposed by the USFDA. The market has become very competitive in the region, which, in turn, is driving the demand for sustainable and high-quality products in this region. To gain a sustainable advantage over the competitors, companies in the area are increasingly offering better packaging solutions.
A significant challenge for the market in this region is the availability of counterfeit drugs and packaging. The United States, which has multiple regulations to prevent the manufacture and distribution of these counterfeit medical products, is witnessing the penetration of fake and substandard drugs in the market.

Furthermore, in 2020, MedAccred announced to continue its expansion and support for the medical device industry. MedAccred has added new sterile device packaging and plastics mechanical assembly audit processes, added four new subscribers and accredited many new suppliers within the last year. The program is also entering its second year of partnering with the US Department of Commerce through the Medical Manufacturers MedAccred Accreditation Pathway (MedMMAP) for manufacturers and suppliers seeking accreditation.

Sterile Medical Packaging Company and Competitive Landscape

The global sterile medical packaging market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include Amcor PLC, Dupont De Nemours, Inc., West Pharmaceutical Services, Inc., Sonoco Products Company, 3M Company, Ampac Group, Oracle Packaging, Steripack Ltd, Wipak Group, and Placon Corporation, among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which contribute to the market's growth globally. For instance, in August 2021, The US Department of Defense (DoD), in collaboration with the Department of Health and Human Services (HHS), has approved SteriPack Group ("SteriPack") a USD 14.743 million contract to develop domestic production capability for XpressCollectTM used in support of COVID-19 diagnostic testing.

Related Reports:

hypovolemic shock market https://www.datamintelligence.com/research-report/hypovolemic-shock-market
tretinoin market https://www.datamintelligence.com/research-report/tretinoin-market
insulin biosimilars market https://www.datamintelligence.com/research-report/insulin-biosimilars-market
antibody mediated rejection market https://www.datamintelligence.com/research-report/antibody-mediated-rejection-market
nasal polyposis drugs market https://www.datamintelligence.com/research-report/nasal-polyposis-drugs-market
north america infusion pumps market https://www.datamintelligence.com/research-report/north-america-infusion-pumps-market

Contact Us -
Company Name: DataM Intelligence
Email: info@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence 4Market Research is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.